Rights and permissions
About this article
Cite this article
Infliximab [Remicade]: warning information added to US label. React. Wkly. 1017, 2 (2004). https://doi.org/10.2165/00128415-200410170-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-200410170-00001